Clarametyx Biosciences
PrivateLast Round
Series A
Extension
Aug 4, 2025
Total Funding Raised
$55.59M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Clarametyx Biosciences is a biotechnology company that develops immune-enabling biologic therapies and vaccines targeting bacterial biofilms to treat severe persistent infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Clarametyx Biosciences Comparables
Compare Clarametyx Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Trellis Bioscience | 81% | |
| Peptilogics | 79% | |
| Centauri Therapeutics Limited | 77% | |
Clarametyx Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Aug 4, 2025 | ||||
| Series A Extension | May 1, 2025 | ||||
| Grant | Jan 7, 2025 | ||||
| Series A | Jan 5, 2024 | ||||
| Grant | Apr 4, 2022 | ||||
Convertible Debt | Aug 31, 2021 |
Clarametyx Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CARB-X | Grant |
| Kineticos Ventures | Grant |
| CincyTech | Series A Extension |
| Cystic Fibrosis Foundation | Series A |
| Rev1 Ventures | Seed, Series A |
| Ohio Innovation Fund | Series A |
| JobsOhio | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 59% MoM.
- May 1, 2025
Raised Series A Extension with CincyTech and kineticos-amr-accelerator-fund-i.
Clarametyx Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Clarametyx Biosciences's valuation, stock price, and market status.